[1] Urist MR. Bone formation by autoinduction[J].Science,1965,150(698):893-899.
[2] Martínez A, Arana P, Fernandez A, et al. Synthesis and characterisation of alginate/chitosan nanoparticles as tamoxifen controlled delivery systems[J].J Microencapsul, 2013,30(4):398-408.
[3] 杨强, 彭江, 卢世璧, 等. 软骨细胞外基质与壳聚糖复合制备组织工程软骨支架及其性能研究[J].中华骨科杂志, 2011, 31(8):904-910.
[4] Wink JD, Gerety PA, Sherif RD, et al. Sustained delivery of rhBMP-2 by means of Poly(Lactic-co-Glycolic Acid) microspheres: cranial bone regeneration without heterotopic ossification or craniosynostosis[J]. Plast Reconstr Surg, 2014, 134(1): 51-59.
[5] 王玮, 尹庆水, 张余. 重组人骨形态发生蛋白-2壳聚糖纳米微球的制备及检测[J].中国骨与关节损伤杂志, 2011,26(7):598-600.
[6] 夏远军, 章莹, 李丽华, 等. 重组人骨形态发生蛋白-2/壳聚糖/硫酸葡聚糖复合微球对SD大鼠骨髓基质干细胞诱导及分化作用实验研究[J].中华创伤骨科志, 2014, 16(5):421-426.
[7] 夏远军,余翔,章莹,等.BMP-2/壳聚糖/硫酸葡聚糖复合微球诱导异位成骨的Micro-CT评价[J].中国修复重建外科杂志, 2016, 30(3):286-291.
[8] Jun SH, Lee EJ, Jang TS, et al. Bone morphogenic protein-2 (BMP-2) loaded hybrid coating on porous hydroxyapatite scaffolds for bone tissue engineering[J].J Mater Sci Mater Med,2013, 24(3):773-782.
[9] Kanczler JM, Ginty PJ, Barry JA, et al. The effect of mesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation[J]. Biomaterials, 2008, 29(12): 1892-1900.
[10]Huang D, Zuo Y, Zou Q, et al. Reinforced nanohydroxyapatite/polyamide66 scaffolds by chitosan coating for bone tissue engineering[J]. J Biomed Mater Res B Appl Biomater, 2012,100(1):51-57.
[11]Palazzo B, Gallo A, Casillo A, et al. Fabrication, characterization and cell cultures on a novel composite chitosan-nano-hydroxyapatite scaffold[J].Int J Immunopathol Pharmacol, 2011, 24(1 Suppl 2):73-78.
[12]Patel ZS, Ya mamoto M, Ueda H, et al. Biodegradable gelatin microparticles as deliveiy systems for the controlled release of bone morphogenetic Protein-2[J]. Acta Bioniater, 2008, 4(5):l 126-1138.
[13]Guliyeva U, Oner F, Ozsoy S, et al. Chitosan microparticles containing plasmid DNA as potential oral gene delivery system[J].Eur J Pharm Biopharm, 2006, 62(1):17-25.
[14] Shah RK, Moncayo VM, Smitson RD, et al. Recombinant human bone morphogenetic protein 2-induced heterotopic ossification of the retroperitoneum, psoas muscle, pelvis and abdominal wall following lumbar spinal fusion[J]. Skeletal Radiol, 2010, 39(5):501-504.
[15] Inoda H, Yanmmoto G, Hattori T. rhBMP2 induced ectopic bone for grafting critical size defects: a preliminary histological evaluation in rat calvariae[J]. Int J Oral Maxillofac Surg, 2007, 36(1): 39-44.
[16]Iwata H, Sakano S, Itoh T, et al. Demineralized bone matrix and native bone morphgenetic protein in orthpadic surgery[J] .Clin Orthop, 2002, 395:99-109.
[17]Nakagawa T, Tagawa T. UItrastructural study of direct bone formation induced by Uitrastructural study of direct bone formation induced by BMPs-collagen complex implanted into an ecropic site[J].Oral Dis, 2000, 6(3):172-179.
[18]Vehof JW, Takita H, Kuboki Y, et al. Histological characterization of the carly stages of bone morphpgenetic protein-induced osteogencsis[J].J Biomed Mater Res, 2002, 61(3):440-449.
[19] Sullad AG,Manjeshwar LS,Aminabhavi TM. Novel Semi-interpenetrating microspheres of dextran-grafted-acrylamide and poly(Vinyl Alcohol) for controlled release of abacavir sulfate[J]. Indu strial & Engineering Chemistry Research, 2011, 50(21): 11778-11784.
[20] Gribova V, Crouzier T, Picart C. A material’s point of view on recent developments of polymeric biomaterials: control of mechanical and biochemical properties[J]. J Mater Chem, 2011, 21(38), 14354-14364.
[21]Lee KY, Mooney DJ. Alginate: properties and biomedical applications[J]. Prog Polym Sci, 2012, 37(1):106-126.
[22] Wang M, Abbah SA, Hu T,et al. Minimizing the severity of rhBMP-2-induced inflammation and heterotopic ossification with a polyelectrolyte carrier incorporating heparin on microbead templates[J]. Spine, 2013, 38(17):1452-1458.
[23]Hudalla GA, Murphy WL. Biomaterials that regulate growth factor activity via bioinspired interactions[J]. Adv Funct Mater, 2011, 21(10):1754-1768 . |